Assessment of Circulating Tumor DNA in Newly Diagnosed DLBCL Patients Randomly Treated By R-CHOP or R-High Dose Chemotherapy Plus Autologous Stem Cell Support - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Blood Année : 2021

Assessment of Circulating Tumor DNA in Newly Diagnosed DLBCL Patients Randomly Treated By R-CHOP or R-High Dose Chemotherapy Plus Autologous Stem Cell Support

Résumé

Meeting Abstract 3501

Dates et versions

hal-03770252 , version 1 (06-09-2022)

Identifiants

Citer

Fabienne Desmots-Loyer, Delphine Rossille, Mikaël Roussel, Steven Le Gouill, Thierry Lamy, et al.. Assessment of Circulating Tumor DNA in Newly Diagnosed DLBCL Patients Randomly Treated By R-CHOP or R-High Dose Chemotherapy Plus Autologous Stem Cell Support. Blood, 2021, 138 (suppl 1), ⟨10.1182/blood-2021-145035⟩. ⟨hal-03770252⟩
12 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More